Session Chairs: Ingo Lindner, Roche Diagnostics GmbH and Hillary Schuessler, Merck & Co., Inc.

Session Speakers:

Advanced MS-based Technologies to Tackle Characterization Challenges of Complex Formats and New Modality Biotherapeutics

Feng Yang, Genentech, A Member of the Roche Group

High-throughput Screening Strategies to Characterize Protein Conjugation

Anumita Saha, Merck & Co., Inc.

Use of Multi-Attribute Methods for In-Process Monitoring and Quality Control of Complex Biologics

Anita Liu, Merck & Co., Inc.

Anumita Saha